Chronic lymphocytic leukemia (CLL), the most common hematologic malignancy in Western countries, is characterized by the accumulation in the blood of monoclonal CD5+ CD19+ CD23+ B lymphocytes mainly arrested in G0/G1 phase of the cell cycle. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.